Units, each consisting of one share of Class A Common Stock, $0.0001 par value, and one-half of one Redeemable Warrant NASDAQ NASDAQ Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 NASDAQ 0001845991 false 0001845991 2023-01-08 2023-01-08 0001845991 lionu:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember 2023-01-08 2023-01-08 0001845991 us-gaap:CommonClassAMember 2023-01-08 2023-01-08 0001845991 lionu:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2023-01-08 2023-01-08

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

January 8, 2023

Date of Report (Date of earliest event reported)

 

 

Lionheart III Corp

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-41011   36-4981022

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

4218 NE 2nd Avenue, Miami, FL   33137
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (305) 573-3900

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol

 

Name of each exchange

on which registered

Units, each consisting of one share of Class A Common Stock, $0.0001 par value, and one-half of one Redeemable Warrant   LIONU   The Nasdaq Capital Market LLC
Shares of Class A common stock included as part of the units   LION   The Nasdaq Capital Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one share of the Class A common stock at an exercise price of $11.50   LIONW   The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 1.01

Entry into a Material Definitive Agreement.

On January 8, 2023, Lionheart III Corp (the “Company”), Security Matters Limited (“SMX”) and Empatan PLC (“Parent”) entered into a Deed of Variation - Scheme Implementation Deed (the “Deed of Variation”) to the previously announced Scheme Implementation Deed dated July 26, 2022 between the parties (the “SID”) to, among other things, implement certain amendments to the SID that were requested by the Australian Securities and Investments Committee (“ASIC”) in connection with ASIC’s required review of the transaction, including changes to the definitions of “Lionheart Material Adverse Effect” and “SMX Material Adverse Effect”. All other terms of the SID remain unchanged.

The foregoing description of the Deed of Variation is qualified in its entirety by references to the full text of such document, a copy of which is filed herewith as Exhibit 2.1. 

 

Item 8.01

Other Events.

First Court Hearing - Scheme of Arrangement

On January 9, 2023, SMX appeared before the Federal Court of Australia (the “Court”) for the First Court Hearing to seek approval from the Court of the Scheme Meeting and Option Scheme Meeting for SMX shareholders and optionholders, respectively. At the hearing, the Court approved the distribution of a Scheme Booklet to shareholders and optionholders and the convening of a meeting of shareholders and a separate meeting of optionholders, to vote on and approve respective schemes. The Share Scheme Meeting is to be held at 9:00 a.m., Melbourne time, on February 1, 2023, with the Option Scheme Meeting to follow at 9:30 a.m., Melbourne time. The General Meeting will be held at 10:00 a.m., Melbourne time, on February 1, 2023 to approve the capital reduction in connection with the Schemes. A further hearing is scheduled for January 23, 2023 to seek approval of supplementary disclosure materials from the Court and a further hearing to approve the Schemes (if approved at the respective meetings) is set for February 6, 2023.

Important Information and Where to Find It

In connection with the potential business combination (the “proposed business combination”), a registration statement on Form F-4 (the “Form F-4”) was filed by Empatan Public Limited Company, a public limited company incorporated in Ireland with registered number 722009 (the “Parent”) with the U.S. Securities and Exchange Commission (the “SEC”). Upon the closing of the proposed business combination, it is expected that the Parent will be the ultimate parent of Lionheart III Corp (“Lionheart”) and Security Matters Limited (“SMX”). The Form F-4 includes a preliminary proxy statement /prospectus to be distributed to holders of Lionheart’s common stock in connection with Lionheart’s solicitation of proxies for the vote of its stockholders in connection with the proposed business combination and other matters as described in the Form F-4, as well as a prospectus relating to the offer and sale of securities to be issued in connection with the completion of the business combination. This document does not contain all the information that should be considered concerning the proposed business combination and is not intended to form the basis of any investment decision or any other decision in respect of the proposed business combination. Lionheart and SMX urge investors, stockholders and other interested persons to read the Form F-4, including the proxy statement/prospectus included therein and the amendments thereto as well as any other documents filed with the SEC in connection with the proposed business combination as these materials will contain important information about SMX, Lionheart, the Parent and the proposed business combination. After the Form F-4 has been declared effective, the definitive proxy statement/prospectus will be mailed to Lionheart’s stockholders as of the record date established for voting on the proposed business combination. Lionheart’s stockholders will also be able to obtain copies of such documents, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: Lionheart III Corp, 4218 NE 2nd Avenue, Miami, Florida 3313.

INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED THEREIN.

Participants in the Solicitation of Proxies

This communication is not a solicitation of a proxy from any investor or securityholder. Lionheart, SMX, and their respective directors, executive officers and other members of their management and employees, may, under SEC rules, be deemed to be participants in the solicitation of proxies of Lionheart’s stockholders in connection with the proposed business combination. Investors and securityholders may obtain more detailed information regarding the names, affiliations and interests of Lionheart’s directors and executive officers in Lionheart’s Annual Report on Form 10-K filed with the SEC on April 14, 2022, the proxy statement/prospectus, other relevant materials filed with the SEC in connection with the proposed business combination when they become available, and other reports filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

 

 

2


No Offer or Solicitation

No offer or offering of equity interests or securities of any kind is being made, conducted or extended at this time. This communication is for informational purposes only and does not constitute or include an offer to sell, or a solicitation of an offer to purchase or subscribe for, equity interests or securities of any kind or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of any such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Any such offer or solicitation will be made only in connection with the delivery of a prospectus meeting the requirements of the Securities Act of 1933, as amended (“Securities Act”), or exemptions therefrom.

Forward-Looking Statements

This communication includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including the identification of a target business and potential business combination or other such transaction, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section entitled “Risk Factors” in the annual report on Form 10-K filed by Lionheart on April 14, 2022 and the proxy statement/prospectus filed relating to the proposed business combination. Important factors, among others, that may affect actual results or outcomes include: (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii) the inability of SMX and Lionheart to successfully or timely consummate the proposed business combination, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed business combination or that the approval of the stockholders of Lionheart or equity holders of SMX is not obtained; (iii) failure to realize the anticipated benefits of the proposed business combination;(iv) SMX’s limited operating history; (v) SMX’s ability to grow and manage its growth effectively; (vi) SMX’s ability to execute its business plan; (vii) SMX’s estimates of the size of the markets for its products; (viii) the rate and degree of market acceptance of SMX’s products; (ix) SMX’s ability to identify and integrate acquisitions; (x) SMX’s future investments in its technology and operations; (xi) potential litigation involving Lionheart or SMX or the validity or enforceability of SMX’s intellectual property; (xii) risks relating to the uncertainty of the projected financial information with respect to SMX; (xiii) the effects of competition on SMX’s business; (xiv) developments and changes in laws and regulations; (xv) the impact of significant investigative, regulatory or legal proceedings; (xvi) general economic and market conditions impacting demand for SMX’s products and services; (xvii) the amount of redemption requests made by Lionheart’s public stockholders; (xviii) the amount of cash available following any redemptions by Lionheart stockholders; (xix) the ability to meet Nasdaq’s listing standards following the consummation of the proposed transaction; (xx) the ability of Lionheart or the combined company to issue equity or equity-linked securities in connection with the proposed business combination or in the future; and such other risks and uncertainties as are discussed in the Lionheart’s annual report on Form 10-K filed with the SEC on April 14, 2022 and the proxy statement/prospectus filed relating to the proposed business combination. Other factors include the possibility that the proposed business combination does not close, including due to the failure to receive required security holder approvals, or the failure of other closing conditions. Lionheart expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Lionheart’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

 

Item 9.01

Financial Statement and Exhibits.

(d) Exhibits.

 

Exhibit

Number

  

Description

2.1    Deed of Variation - Scheme Implementation Deed dated January 8, 2023, between Lionheart III Corp, Empatan PLC and Security Matters Limited.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 11, 2023
LIONHEART III CORP
By:  

/s/ Ophir Sternberg

Name:   Ophir Sternberg
Title:   Chairman, President and Chief Executive Officer

 

4

Exhibit 2.1

 

LOGO

Deed of Variation - Scheme

Implementation Deed

Lionheart III Corp

and

Empatan PLC

and

Security Matters Limited

ACN 626 192 998

 


Table of Contents

 

1.

   Definitions and interpretation    1

1.1

   Definitions    1

1.2

   Interpretation    1

2.

   Variation of SID    2

2.1

   Variation    2

2.2

   Confirmation of the SID    3

2.3

   Prior rights and obligations not affected    3

3.

   Inconsistency    3

4.

   General    3

4.1

   Severability    3

4.2

   No variation    3

4.3

   Execution and delivery    3

4.4

   Counterparts    4

4.5

   Governing law and jurisdiction    4


Deed of Variation

Date  08 January 2023

Parties

 

1.

Lionheart III Corp a Delaware Corporation of 4218 NE 2nd Avenue, Miami, FL 33137 (Lionheart)

 

2.

Empatan PLC a public limited company incorporated in Ireland with registered number 722009 and a registered address at Mespil Business Centre, Mespil House, Sussex Road, Dublin 4, Ireland, D04 T4A6 (Parent)

 

3.

Security Matters Limited ACN 626 192 998 of Level 25, 525 Collins Street, Melbourne, Victoria 3000 (SMX)

Background

 

A.

The parties are parties to the SID.

 

B.

The parties wish to vary the SID as set out in this Deed to implement changes requested by ASIC and to update further matters.

Agreed terms

 

1.

Definitions and interpretation

 

1.1

Definitions

 

  (a)

In this Deed:

ASIC means Australian Securities and Investments Committee;

Business Day means a day that is not a Saturday, Sunday, public holiday or bank holiday in Melbourne;

Deed means this deed including the background, any schedules and any annexures;

Effective Date means the date of this deed;

SID means the Scheme Implementation Deed made between the parties and dated 26 July 2022; and

 

  (b)

Unless otherwise indicated, words or expressions defined in the Deed have the same meaning in this deed.

 

1.2

Interpretation

In this Deed, unless the context requires otherwise:

 

  (a)

the singular includes the plural and vice versa;

 

  (b)

a gender includes the other genders;


  (c)

headings are used for convenience only and do not affect the interpretation of this Deed;

 

  (d)

other grammatical forms of a defined word or expression have a corresponding meaning;

 

  (e)

a reference to a document is to that document as amended, novated, supplemented, extended or restated from time to time;

 

  (f)

a reference to a party is to a party to this deed and includes that party’s executors, administrators, successors, permitted assigns and permitted substitutes;

 

  (g)

“person” includes a natural person, partnership, body corporate, association, joint venture, governmental or local authority, and any other body or entity whether incorporated or not;

 

  (h)

a reference to all or any part of a statute, rule, regulation or ordinance (statute) is to that statute as amended, consolidated, re-enacted or replaced from time to time;

 

  (i)

“include”, “for example” and any similar expressions are not used, and must not be interpreted, as words of limitation;

 

  (j)

a reference to any agency or body that ceases to exist, is reconstituted, renamed or replaced, or has its powers or functions removed (defunct body) is to the agency or body that performs most closely the powers or functions of the defunct body;

 

  (k)

any provision in this Deed which is in favour of more than one person benefits all of them jointly and each of them severally; and

 

  (l)

any provision in this Deed which binds more than one person binds all of them jointly and each of them severally.

 

2.

Variation of SID

 

2.1

Variation

With effect on and from the Effective Date, the SID is varied by:

 

  (a)

replacing the definition of Cashless Exercise in the Option Scheme with the revised definition set out in Part A of Schedule 1;

 

  (b)

replacing the definition of Lionheart Material Adverse Effect to the revised definition set out in Part B of Schedule 1;

 

  (c)

replacing the definition of SMX Material Adverse Effect to the revised definition set out in Part C of Schedule 1;

 

  (d)

delete the wording “and acting reasonably” from clause 7.1(a)(i);

 

  (e)

delete the wording “and acting reasonably” from clause 7.1(b)(i);

 

  (f)

delete the wording “and acting reasonably” from clause 7.2; and

 

2


  (g)

the parties acknowledge that the share capital of SMX has changed since the execution of the SID and the changes set out below are to replace the incorrect share capital currently contained in the SID:

 

  (i)

a total of 167,854,581 SMX Shares on issue;

 

  (ii)

a total of 32,122,957 SMX Options on issue; and

 

  (iii)

a total of 13,050,114 ESOP Options on issue.

 

2.2

Confirmation of the SID

All provisions of the SID other than those varied by clause 2.1 remain unchanged and continue in full force.

 

2.3

Prior rights and obligations not affected

 

3.

This Deed does not affect the rights and obligations of the parties to the extent that they relate to the period prior to the Effective Date.Inconsistency

If there is any inconsistency between the provisions of this Deed and the provisions of the SID, then the provisions of this Deed prevail to the extent of that inconsistency.

 

4.

General

 

4.1

Severability

Any provision of this Deed which is invalid in any jurisdiction must, in relation to that jurisdiction:

 

  (a)

be read down to the minimum extent necessary to achieve its validity, if applicable; and

 

  (b)

be severed from this Deed in any other case,

without invalidating or affecting the remaining provisions of this Deed or the validity of that provision in any other jurisdiction.

 

4.2

No variation

This Deed cannot be amended or varied except in writing signed by the parties.

 

4.3

Execution and delivery

By executing this Deed, a party intends:

 

  (i)

to be immediately bound by this Deed; and

 

  (ii)

for such execution to constitute delivery of this Deed to each other party.

 

3


  (b)

Nothing in this clause 4.3 should be taken to exclude any statutory or common law principle applicable to the proper execution and delivery of a deed.

 

  (c)

This clause 4.3 supersedes, terminates and replaces any prior agreements and communications between the parties which indicate that the agreements recorded in this Deed are “subject to contract” or similar arrangements.

 

4.4

Counterparts

If this Deed consists of a number of signed counterparts, each is an original and all of the counterparts together constitute the same document. A party may sign a counterpart by executing a signature page and electronically transmitting a copy of the signed page to each other party or their authorised representative. Signatures on behalf of one party that are on different counterparts will be taken to be, and have the same effect as, signatures on the same counterpart and on a single copy of this Deed.

 

4.5

Governing law and jurisdiction

 

  (a)

This Deed is governed by and must be construed in accordance with the laws of Victoria.

 

  (b)

The parties submit to the exclusive jurisdiction of the courts of that State and the Commonwealth of Australia in respect of all matters arising out of or relating to this Deed, its performance or subject matter.

 

4


Schedule 1

Part A

Definition—Cashless Exercise

Cashless Exercise means the exercise of that portion of Scheme Options held by each Option Scheme Participant, with the exercise price of such options being reduced to nil, and the expiry of the balance of Scheme Options held by that Option Scheme Participant occurring on the Implementation Date, such that each Option Scheme Participant receives the number of Option Exercise Shares determined in accordance with the Schedule and following which all Scheme Options of the Option Scheme Participant have either been exercised or have expired.

Part B

Definition—Lionheart Material Adverse Effect

Lionheart Material Adverse Effect means any event, matter or circumstance which has, or would be reasonably likely to have, either individually or when aggregated with any other events, matters or circumstances:

 

  (a)

a material adverse effect on the assets, liabilities, financial condition, business or results of operations of the Lionheart Group (taken as a whole); and

 

  (b)

the effect of diminishing the value of the net assets of the Lionheart Group (which net assets shall include the assets in the Trust Fund) by an amount of 20% or more, as compared to the value of the net assets of the Lionheart Group set out in the most recent accounts disclosed to the SEC prior to the date of this Deed, excluding any diminishment of such net assets resulting from redemptions from the Trust Fund,

but does not include events, matters or circumstances to the extent resulting from or arising out of:

 

  (c)

changes in general economic, industry, regulatory or political conditions, the securities or other capital markets in general or law;

 

  (d)

any epidemic, pandemic (including COVID-19 or COVID-19 Measures), hurricane, earthquake, flood, weather conditions, calamity or other natural disaster, act of God or other force majeure event (or any worsening of or recovery from any of the foregoing);

 

  (e)

geopolitical conditions, hostilities, civil or political unrest, any acts of war, sabotage, or terrorism (including any outbreak, escalation or worsening of any of the foregoing);

 

  (f)

any change in taxation rates, interest rates or exchange rates;

 

  (g)

any change in generally accepted accounting principles or the authoritative interpretation of them;

 

  (h)

the taking of any action required under this document, the BCA, the Schemes or the transactions contemplated by them, including the Transactions (other than, to the extent not excluded by another clause of this definition, Lionheart’s compliance with its obligations pursuant to clause 9);

 

5


  (i)

any change in the market price or trading volume of Lionheart Shares or the Lionheart Warrants (but this exception will not prevent the underlying cause or contributing factor of any such change, if not falling within any other exception in this definition, from being taken into account in determining whether there has been a Lionheart Material Adverse Effect);

 

  (j)

any failure, in and of itself, by Lionheart or a member of the Lionheart Group to meet any internal or published projections, forecasts, estimates or predictions of revenues, earnings or other financial or operating metrics for any period (but this exception will not prevent the underlying cause or contributing factor of any such failure, if not falling within any other exception in this definition, from being taken into account in determining whether there has been a Lionheart Material Adverse Effect);

 

  (k)

the execution, delivery or performance of this document or the BCA, or the announcement of the Schemes or the other transactions contemplated by this document or the BCA (including in the impact of any of the foregoing on the relationship of Lionheart or a member of the Lionheart Group with their respective employees, customers, creditors, suppliers or contractual counterparties), provided that this clause (i) shall not apply with respect to any representation or warranty that addresses the consequences of the execution, delivery or performance of this document or the announcement or pendency of the Scheme or the BCA or the other transactions contemplated by this document or the BCA or with respect to the Conditions Precedent that relate to such representations or warranties;

 

  (l)

the identity of, or any facts or circumstances relating to, SMX or any member of the SMX Group;

 

  (m)

any actions, suits or claims arising from allegations of a breach of fiduciary duty or violation of securities laws, in each case relating to this document, the Schemes, the BCA or the transactions contemplated by this document or the BCA; or

 

  (n)

any action (or the failure to take any action) with the written consent or at the written request of SMX,

except, in the case of each of the foregoing clauses (a), (b), (c), (d) and (e), if the effects of such events, matters or circumstances are disproportionately adverse to the Lionheart Group as compared to the effects on other companies in the industry in which the Lionheart Group operates, and then solely to the extent of such disproportionate effect.

Part C

Definition—SMX Adverse Effect

SMX Material Adverse Effect means any event, matter or circumstance which has, or would be reasonably likely to have, either individually or when aggregated with any other events, matters or circumstances,

 

  (a)

a material adverse effect on the assets, liabilities, financial condition, business or results of operations of the SMX Group (taken as a whole); and

 

6


  (b)

the effect of diminishing the value of the net assets of the SMX Group by an amount of 20% or more, as compared to the value of the net assets of the SMX Group set out in the 30 June 2022 accounts,

but does not include events, matters or circumstances to the extent resulting from or arising out of:

 

  (c)

changes in general economic, industry, regulatory or political conditions, the securities or other capital markets in general or law;

 

  (d)

any epidemic, pandemic (including COVID-19 or COVID-19 Measures), hurricane, earthquake, flood, weather conditions, calamity or other natural disaster, act of God or other force majeure event (or any worsening of or recovery from any of the foregoing);

 

  (e)

geopolitical conditions, hostilities, civil or political unrest, any acts of war, sabotage, or terrorism (including any outbreak, escalation or worsening of any of the foregoing);

 

  (f)

any change in taxation rates, interest rates or exchange rates;

 

  (g)

any change in generally accepted accounting principles or the authoritative interpretation of them;

 

  (h)

the taking of any action required under this document, the BCA, the Schemes or the transactions contemplated by them, including the Transactions (other than, to the extent not excluded by another clause of this definition, SMX’s compliance with its obligations pursuant to clause 9);

 

  (i)

any change in the market price or trading volume of SMX Shares (but this exception will not prevent the underlying cause or contributing factor of any such change, if not falling within any other exception in this definition, from being taken into account in determining whether there has been an SMX Material Adverse Effect);

 

  (j)

any failure, in and of itself, by SMX or a member of the SMX Group to meet any internal or published projections, forecasts, estimates or predictions of revenues, earnings or other financial or operating metrics for any period (but this exception will not prevent the underlying cause or contributing factor of any such failure, if not falling within any other exception in this definition, from being taken into account in determining whether there has been an SMX Material Adverse Effect);

 

  (k)

the execution, delivery or performance of this document or the BCA, or the announcement of the Schemes or the other transactions contemplated by this document or the BCA (including the impact of any of the foregoing on the relationship of SMX or a member of the SMX Group with their respective employees, customers, creditors, suppliers or contractual counterparties), provided that this clause (i) shall not apply with respect to any representation or warranty that addresses the consequences of the execution, delivery or performance of this document or the announcement of the Schemes or the other transactions contemplated by this document or the BCA or with respect to the Conditions Precedent that relate to such representations or warranties;

 

  (l)

the identity of, or any facts or circumstances relating to, Lionheart or any member of the Lionheart Group;

 

7


  (m)

actions, suits or claims arising from allegations of a breach of fiduciary duty or violation of securities laws, in each case relating to this document, the Schemes or the BCA or the transactions contemplated by this document or the BCA; or

 

  (n)

any action (or the failure to take any action) with the written consent or at the written request of Lionheart,

except, in the case of each of the foregoing clauses (a), (b), (c), (d) and (e), if the effects of such events, matters or circumstances are disproportionately adverse to the SMX Group as compared to the effects on other companies in the industry in which the SMX Group operates, and then solely to the extent of such disproportionate effect.

Executed as a deed

 

Signed for and on behalf of Lionheart III Corp

by its duly authorised representative:

   
   
   

/s/ Paul Rapisarda

   

Signature of authorised representative

By executing this agreement the representative

staters that they have received no notice that their

authority to do so has been revoked

   

Paul Rapisarda

    Name (please print)

Signed and delivered for and on behalf of and

as a deed of Empatan PLC by its lawful

appointed attorney in the presence of:

   

/s/ Doron Afik

   

/s/ Haggai Alon                                     /s/ Amir Bader

Signature of witness     Signature of attorney

Doron Afik

   

Haggai Alon                                           Amir Bader

Name of witness (please print)     Name of attorney (please print)

103 Hahashmonaim St., Tel Aviv, Israel

   
Address of witness    

Attorney

   
Occupation of witness    

 

8


Executed by Security Matters Limited ACN

626 192 998 in accordance with section 127(1)

of the Corporations Act 2001 (Cth):

   

/s/ Ed Hofland

   

/s/ Haggai Alon

Signature of director     Signature of director

Ed Hofland

   

Haggai Alon

Name (please print)     Name (please print)